Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Behavior × 30 days × Clear all

Phase

Phase NA 2 Phase 4 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8 Stomach Neoplasms 4 Prostatic Neoplasms 4 Uterine Cervical Neoplasms 3 Waldenstrom Macroglobulinemia 2 Tuberous Sclerosis 2 Skin Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Myasthenia Gravis 2 Multiple Myeloma 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hypertension 2 Colorectal Neoplasms 2 Warts 1 Venous Thromboembolism 1 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Diseases 1 Urogenital Diseases 1 Urinary Bladder Neoplasms 1 Tuberculosis, Pulmonary 1 Thyroid Neoplasms 1 Thoracic Neoplasms 1 Thoracic Diseases 1 Thalassemia 1 Synovial Cyst 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05864846 2026-03-12

EpiCom

Jazz Pharmaceuticals

Phase 4 Active not recruiting

Behavior, Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡